RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery

Clinical trial NCT00168805 · COMPLETED

Trial details

NCT number: NCT00168805
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthroplasty, Replacement, Knee Thromboembolism

Start date: 2004-11-01
Primary completion: 2006-05-01
Enrollment: 2101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.